Skip to main content

Table 1 Baseline characteristics and demographics of randomized participants in the Canadian subpopulation

From: Randomized controlled trial of ragweed sublingual immunotherapy tablet in the subpopulation of Canadian children and adolescents with allergic rhinoconjunctivitis

 

Ragweed SLIT-Tablet

(n = 116)

Placebo

(n = 130)

Male, n (%)

67 (57.8)

78 (60.0)

Age, mean (SD) y

12.5 (3.2)

12.4 (3.2)

 < 12 y, n (%)

46 (39.7)

51 (39.2)

 ≥ 12 y, n (%)

70 (60.3)

79 (60.8)

White, n (%)

101 (87.1)

115 (88.5)

Participants with asthma, n (%)

38 (32.8)

50 (38.5)

IgE sensitization type, n (%)

 Ragweed only

9 (7.8)

14 (10.8)

 Ragweed and other allergens

107 (92.2)

116 (89.2)

  Alder tree

68 (58.6)

74 (56.9)

  Alternaria tenuis

47 (40.5)

47 (36.2)

  Birch tree

74 (63.8)

81 (62.3)

  Cat dander

74 (63.8)

94 (72.3)

  Cladosporium herbarum

28 (24.1)

26 (20.0)

  Dog dander

64 (55.2)

80 (61.5)

  House dust mites

48 (41.4)

60 (46.2)

  Mugwort

65 (56.0)

78 (60.0)

  Timothy grass

70 (60.3)

85 (65.4)

A artemisiifolia SPT wheal size, mean (SD) mm

10.2 (3.0)

10.5 (3.5)

A artemisiifolia serum specific IgE, mean (SD) kUA/L

17.7 (21.5)

20.5 (26.1)

  1. SLIT sublingual immunotherapy, SPT skin prick test